XYPHOS BIOSCIENCES
Summary
Xyphos, a privately held development-stage biotechnology company, is focused on the creation and development of immuno-oncology therapeutics designed to harness the power of the patient's immune system to cure cancer.
Deals Overview
Total Deals0
Valued Deals0
Total Valuevalue n/a
Avg. Deal Sizevalue n/a
No individuals exist
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.